Related Experiment Video
Updated: Jun 9, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
[Radiotherapy and atherosclerosis: current data and issues]
Marie-Hélène Gaugler1, Franck Drouet, Michel Krempf
1IRSN DRPH SRBE, BP n degrees 17, 92262 Fontenay-aux-Roses, France. marie-helene.gaugler@inserm.fr
Abstract:
The continuous optimization of cancer treatment with radiotherapy raises the problem of long-term issue of patients treated and cured by ionizing radiation, with the possible occurrence of second cancers or nonmalignant complications. Among these, cardiovascular diseases are prevalent and may affect up to 40 % of patients depending on the location of the irradiation. Recent epidemiological studies show that this problem is underestimated and with no real prospective studies. The management of these patients with vascular risk, or with very high vascular risk for those with pre-existing traditional cardiovascular risk factors, remains to be determined. The pathophysiological mechanisms of radiation-induced atherosclerosis have not yet been clarified. Many efforts are still needed to identify patients at risk and to find or to propose an appropriate treatment. Prolonged vascular follow-up of patients after their radiotherapy should now be integrated into patterns of care, especially because the setting up of sophisticated technical platforms of radiotherapy do not necessarily solve the issue of cardiovascular risk after treatment. double dagger.
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease I: Introduction
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

